Víctor Velásquez

Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with <scp>V</scp>ogt‐<scp>K</scp>oyanagi‐<scp>H</scp>arada disease

Cristhian A. Urzúa, Víctor Velásquez, Pablo Sabat et al. · Acta Ophthalmologica · 2015 · 49 citations · Full text

Clinical Features and Prognostic Factors in Presumed Ocular Tuberculosis

Cristhian A. Urzúa, Yrbani Lantigua, Sergio Abuauad et al. · Current Eye Research · 2017 · 31 citations · Full text

Evaluation of the Glucocorticoid Receptor as a Biomarker of Treatment Response in Vogt-Koyanagi-Harada Disease

Cristhian A. Urzúa, Julia Guerrero, H Gatica et al. · Investigative Ophthalmology & Visual Science · 2017 · 20 citations · Full text

Machine Learning Approach for Predictive Maintenance in Hydroelectric Power Plants

Víctor Velásquez, Wilfredo C. Flores · 2022 IEEE Biennial Congress of Argentina (ARGENCON) · 2022 · 14 citations

Artificial Intelligence, Fault Diagnosis, Engineering +22

Glucocorticoid Receptor-α and MKP-1 as Candidate Biomarkers for Treatment Response and Disease Activity in Vogt-Koyanagi-Harada Disease

Cristhian A. Urzúa, Ping Chen, Benjamin Chaigne-Delalande et al. · American Journal of Ophthalmology · 2019 · 10 citations